Latest stories on CNSY
Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ™ Doses in Leptomeningeal Metastases
GlobeNewswire56 · neutralproduct/pr
Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ™ Doses in Leptomeningeal Metastases
Business Insider56 · neutralproduct/pr
Cerenome announces new dual mechanism of action for REYOBIQ
The Fly61 · neutralproduct/pr
Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile Tests
GlobeNewswire63 · neutralproduct/pr
Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile Tests
Business Insider63 · neutralproduct/pr
Cerenome Launches CNSide® CSF Molecular Profile Tests
GlobeNewswire65 · bullishproduct/pr
Cerenome Launches CNSide® CSF Molecular Profile Tests
Business Insider63 · neutralproduct/pr
Cerenome Updates Investor Presentation on CNS Oncology Strategy
TipRanks55 · neutralgeneral
CERENOME, INC. (CNSY) files 8-K
SEC 8-K50 · neutralgeneral
Cerenome, Inc. (CNSY) Discusses Diagnostic Division Update and Progress on C-INSIDE Platform Transcript
Seeking Alpha56 · neutralproduct/pr
Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
GlobeNewswire67 · bullishproduct/pr
Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
Business Insider67 · bullishproduct/pr
Cerenome to Hold CNSide® Business Update Call on September 30, 2026
GlobeNewswire55 · neutralgeneral
Cerenome to Hold CNSide® Business Update Call on September 30, 2026
Business Insider55 · neutralgeneral
Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
Business Insider55 · neutralgeneral
Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
GlobeNewswire55 · neutralgeneral
Cerenome Secures New Senior Financing to Extend Runway
TipRanks56 · neutralgeneral
CERENOME, INC. (CNSY) files 8-K
SEC 8-K50 · neutralgeneral
Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
GlobeNewswire59 · neutralgeneral
Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
Business Insider28 · bearishgeneral
Cerenome Launches New Corporate Identity as Integrated CNS Oncology Company
Business Insider55 · neutralgeneral